Fig. 2: APICAL-GC study design.

The clinical trial profile of this study. 40 Patients with AGC with PS 2 were screened and 24 patients were enrolled and treated.

The clinical trial profile of this study. 40 Patients with AGC with PS 2 were screened and 24 patients were enrolled and treated.